Literature DB >> 1530854

Creatinine kinase kinetics studied by phosphorus-31 nuclear magnetic resonance in a canine model of chronic hypertension-induced cardiac hypertrophy.

M Osbakken1, P S Douglas, T Ivanics, D N Zhang, T Van Winkle.   

Abstract

To determine whether cardiac hypertrophy secondary to chronic renovascular hypertension is associated with altered in vivo myocardial metabolism, phosphorus-31 nuclear magnetic resonance saturation transfer techniques were used to study creatine kinase (CK) kinetics in six chronically hypertensive dogs with moderate cardiac hypertrophy and eight control dogs. The forward rate constant of CK and the flux of phosphocreatine to adenosine triphosphate were determined in both groups of dogs before and during norepinephrine administration (1 microgram/kg per min), used to increase heart rate x systolic blood pressure (rate-pressure product), cardiac output and oxygen consumption. Baseline and norepinephrine-induced changes in rate-pressure product, cardiac output and oxygen consumption were similar in both groups of dogs, as were baseline forward rate constant and flux of phosphocreatine to adenosine triphosphate. However, the norepinephrine-induced changes in forward rate constant and flux were significantly less in hypertensive than in control dogs (p less than 0.05) even though changes in hemodynamic and functional variables were similar in both groups. These data demonstrate that moderate myocardial hypertrophy is associated with altered CK kinetics, which do not appear to affect the heart's ability for global mechanical recruitment at this stage in the hypertensive process. It is possible that the changes in myocardial enzyme kinetics may contribute to diastolic dysfunction previously reported in this model and may be a precursor for ultimate development of heart failure if hypertension is maintained for prolonged periods.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1530854     DOI: 10.1016/0735-1097(92)90076-y

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  7 in total

1.  Functional and metabolic evaluation of the hypertrophied heart using MRI and 31P-MRS.

Authors:  H J Lamb; A van der Laarse; B M Pluim; H P Beyerbacht; J Doornbos; E E van der Wall; A de Roos
Journal:  MAGMA       Date:  1998-09       Impact factor: 2.310

2.  Evaluation of myocardial energy status in vivo by NMR spectroscopy.

Authors:  A M Seymour
Journal:  Basic Res Cardiol       Date:  1993 Sep-Oct       Impact factor: 17.165

3.  Exercise training improves age-related myocardial metabolic derangement: proton magnetic resonance spectroscopy study in the rat model.

Authors:  Sang Il Choi; Hyuk-Jae Chang; Eun Ju Chun; Seong Bong Cho; Sang Tae Kim; Yeonyee E Yoon; Sung-A Chang; Jae Hyoung Kim; Cheol-Ho Kim; Tae-Hwan Lim
Journal:  Korean Circ J       Date:  2010-09-30       Impact factor: 3.243

Review 4.  Diastolic function in hypertension.

Authors:  R A Phillips; J A Diamond
Journal:  Curr Cardiol Rep       Date:  2001-11       Impact factor: 2.931

Review 5.  Metabolic regulation of in vivo myocardial contractile function: multiparameter analysis.

Authors:  M D Osbakken
Journal:  Mol Cell Biochem       Date:  1994 Apr-May       Impact factor: 3.396

6.  Bioenergetic abnormalities associated with severe left ventricular hypertrophy.

Authors:  J Zhang; H Merkle; K Hendrich; M Garwood; A H From; K Ugurbil; R J Bache
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

7.  31P-MR spectroscopic imaging in hypertensive heart disease.

Authors:  J-P Heyne; R Rzanny; A Hansch; U Leder; J R Reichenbach; W A Kaiser
Journal:  Eur Radiol       Date:  2006-03-02       Impact factor: 5.315

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.